Back to search

Phase II experience with MDX-1106 (Ono-4538), an anti-PD-1 monoclonal antibody, in patients with selected refractory or relapsed malignancies

Julie R. Brahmer, Suzanne L. Topalian, John D. Powderly, Ira Wollner, Joel Picus
DOI: 10.1200/jco.2009.27.15_suppl.3018
Journal of Clinical Oncology

Data up to Jan 2025

Published2009
Citations23
References0
Fields
MedicineInternal medicineGastroenterologyOncology

Total Citations Per Year

Abstract

References (0)

No references found

Cited By (0)

Loading...
Phase II experience with MDX-1106 (Ono-4538), an anti-PD-1 monoclonal antibody, in… (2009) – Journal of Clinical Oncology | Metascience Observatory Explorer